Published in Synapse on November 01, 1993
Dopaminergic mechanisms of individual differences in human effort-based decision-making. J Neurosci (2012) 1.64
Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action. Br J Pharmacol (2010) 1.41
Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. J Psychiatry Neurosci (2000) 1.35
Measurement of Bmax and Kd with the glycine transporter 1 radiotracer (18)F-MK6577 using a novel multi-infusion paradigm. J Cereb Blood Flow Metab (2015) 0.75
Comparison and evaluation of retrospective intermodality brain image registration techniques. J Comput Assist Tomogr (1997) 2.76
Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology (1982) 1.99
Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr (1984) 1.75
Estimation of left ventricular mass and infarct size from nitrogen-13-ammonia PET images based on pathological examination of explanted human hearts. J Nucl Med (1993) 1.44
Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology (1995) 1.42
Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology (1982) 1.31
Retrospective intermodality registration techniques for images of the head: surface-based versus volume-based. IEEE Trans Med Imaging (1999) 1.23
Synthesis of clozapine analogues and their affinity for clozapine and spiroperidol binding sites in rat brain. J Med Chem (1981) 1.16
Tissue signatures with dual-energy computed tomography. Radiology (1979) 1.13
Intrapleural fibrinolytics in management of empyema thoracis. Chest (1996) 1.04
[18F]fluorodeoxyglucose positron emission tomography in refractory complex partial seizures. Ann Neurol (1983) 1.04
Case report. MR and CT appearance of cardiac hemangioma. J Comput Assist Tomogr (1996) 1.04
Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease. Ann Neurol (1985) 1.03
Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride. Brain Res (1993) 0.97
Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors. Synapse (1993) 0.93
Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med (1995) 0.93
Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey. Int J Appl Radiat Isot (1985) 0.92
Isolated intrathoracic presentation of Mycobacterium avium complex in an immunocompetent child. Pediatr Radiol (2001) 0.91
FDG-SPECT: correlation with FDG-PET. J Nucl Med (1995) 0.90
High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides. J Nucl Med (1991) 0.88
Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand. J Pharmacol Exp Ther (1990) 0.87
Characterization of desamino-5-[125I]iodo-3-methoxy-zacopride ([125I]MIZAC) binding to 5-HT3 receptors in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry (1998) 0.85
High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors. Life Sci (1991) 0.85
Two-dimensional echographic observations in major detachment of a prosthetic aortic valve. Am Heart J (1981) 0.84
Noninvasive detection of acute rejection in a new experimental model of heart transplantation. Ann Thorac Surg (1993) 0.84
Craniopharyngioma: CT and MR imaging in nine cases. J Comput Assist Tomogr (1987) 0.83
Real-time sonographic detection of vesicoureteral reflux in children. AJR Am J Roentgenol (1982) 0.83
Gadolinium-enhanced MR angiography. Radiology (1990) 0.83
On the topology of the norepinephrine transport carrier in rat hypothalamus. The site of action of tricyclic uptake inhibitors. Mol Pharmacol (1978) 0.83
MRI of mumps encephalitis: comparison with CT evaluation. Pediatr Radiol (1987) 0.83
Positron emission tomography imaging-directed stereotactic neurosurgery. Stereotact Funct Neurosurg (1992) 0.82
Down's syndrome in adults: brain metabolism. Science (1983) 0.82
Measurement of blood-brain barrier permeability with positron emission tomography and [68Ga]EDTA. J Cereb Blood Flow Metab (1984) 0.82
Postsurgical outcome of patients with uncontrolled complex partial seizures and temporal lobe hypometabolism on 18FDG-positron emission tomography. Invest Radiol (1996) 0.82
Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine. J Pharmacol Exp Ther (1992) 0.81
Positron emission tomography. Prospects for clinical utility. Invest Radiol (1987) 0.81
Aromatic and amine substituent effects on the apparent lipophilicities of N-[(2-pyrrolidinyl)methyl]-substituted benzamides. J Pharm Sci (1994) 0.80
Esophago-airway fistula in AIDS. Ann Thorac Surg (1995) 0.80
(S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors. J Med Chem (1988) 0.79
Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors. J Pharmacol Exp Ther (1999) 0.78
Comparison of three high affinity SPECT radiotracers for the dopamine D2 receptor. Nucl Med Biol (1994) 0.78
Limbic encephalitis and hyperactive foci on PET scan. Seizure (1999) 0.78
High affinity dopamine D2 receptor radioligands. 3. [123I] and [125I]epidepride: in vivo studies in rhesus monkey brain and comparison with in vitro pharmacokinetics in rat brain. Life Sci (1993) 0.78
Localization of 111In- and 125I-labeled monoclonal antibody in guinea pigs bearing line 10 hepatocarcinoma tumors. Cancer Res (1983) 0.78
Pharmacological characterization of morphine-6-sulfate and codeine-6-sulfate. Brain Res (1999) 0.77
Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides. J Med Chem (1985) 0.77
Magnetic resonance brain tumor imaging in canine glioma. Neurology (1987) 0.77
Dosimetry of iodine-123-epidepride: a dopamine D2 receptor ligand. J Nucl Med (1995) 0.77
Cranial CT in fucosidosis. AJNR Am J Neuroradiol (1982) 0.77
Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-maze. Pharmacol Biochem Behav (2001) 0.77
Noninvasive detection of heart transplant rejection with positron emission scintigraphy. Ann Thorac Surg (1992) 0.77
Autoradiographic localization of dopamine D1 and D2 receptors in rat cerebral cortex following unilateral neurotoxic lesions. Brain Res (1992) 0.77
Selective vulnerability of white matter during spinal cord ischemia. J Cereb Blood Flow Metab (1993) 0.76
Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides. J Med Chem (1986) 0.76
Inhibitory motor seizures: correlation with centroparietal structural and functional abnormalities. Acta Neurol Scand (1995) 0.76
Angiotensin II and coronary sympathetic vasodilation. Circulation (1998) 0.75
Repair of atrial septal defect due to penetrating trauma. Tex Heart Inst J (1993) 0.75
Molecular structure and absolute configuration of the hydrochloride of a novel dopamine receptor antagonist: 2S(-)-5-chloro-3-ethyl-N-[(1-ethyl-2-pyrrolidinyl) methyl]-6-methoxysalicylamide. Acta Pharm Suec (1985) 0.75
Thoracoscopic intercostal nerve blocks. Ann Thorac Surg (1995) 0.75
Solid state conformations and antidopaminergic effects of remoxipride hydrochloride and a closely related salicylamide, FLA 797, in relation to dopamine receptor models. Mol Pharmacol (1986) 0.75
Binding of 5H-dibenzo[b,e][1,4]diazepine and chiral 5H-dibenzo[a,d]cycloheptene analogues of clozapine to dopamine and serotonin receptors. J Med Chem (1994) 0.75
Retrospective registration of PET and MR brain images: an algorithm and its stereotactic validation. J Comput Assist Tomogr (1994) 0.75
Two-dimensional echocardiography and Doppler findings in cerebral arteriovenous malformations. Am J Cardiol (1990) 0.75
Leg function after radiotherapy for Ewing's sarcoma. Cancer (1981) 0.75
Potential antipsychotic agents 5. Synthesis and antidopaminergic properties of substituted 5,6-dimethoxysalicylamides and related compounds. J Med Chem (1990) 0.75
Synthesis and radiolabeling of (S)-4-amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the active enantiomer of [125I]iodozacopride, and re-evaluation of its 5-HT3 receptor affinity. Chem Pharm Bull (Tokyo) (1997) 0.75
Sterically hindered 5,11-dicarbo analogues of clozapine as potential chiral antipsychotic agents. J Med Chem (1989) 0.75
Handgrip exercise in normal young women: a noninvasive cardiovascular assessment. South Med J (1982) 0.75
Cooperative T1 and T2 effects on contrast using a new driven inversion spin-echo (DISE) MRI pulse sequence. Magn Reson Med (1990) 0.75
Accurate localization of cortical convolutions in MR brain images. IEEE Trans Med Imaging (1996) 0.75
Synthesis and 5-HT-3 receptor binding of 2- and 3-(halo)alkoxyl substituted (S)-N-(1-azabicyclo[2.2.2]oct-3-yl)-5-chlorobenzamides as potential radioligands. Nucl Med Biol (1998) 0.75
Optimum energy for performing CT iodinated constrast studies. Br J Radiol (1980) 0.75
Binding of 5H-dibenzo[a,d]cycloheptene and dibenz[b,f]oxepin analogues of clozapine to dopamine and serotonin receptors. J Med Chem (1995) 0.75
Left ventricular size and function in women receiving oral contraceptives. Obstet Gynecol (1980) 0.75
Chloro-substituted, sterically hindered 5,11-dicarbo analogues of clozapine as potential chiral antipsychotic agents. J Med Chem (1990) 0.75
Strain differences in uptake, pool size and turnover rate of norepinephrine in hearts of mice. Biochem Pharmacol (1970) 0.75
Central nervous system lesions in pediatric patients: Gd-DTPA-enhanced MR imaging. Radiology (1988) 0.75
Multiple polyposis and adenocarcinoma arising in Barrett's esophagus. Ann Thorac Surg (1996) 0.75
[125I]iodopride: a specific high affinity radioligand for labelling striatal dopamine D-2 receptors. Eur J Pharmacol (1988) 0.75
Impaired ventilation in a patient with angiographically demonstrated pulmonary emboli. Radiology (1975) 0.75
Positron emission computed tomography (PECT) in refractory complex partial seizures. Trans Am Neurol Assoc (1981) 0.75
Central venous line location in tricuspid endocarditis. Am Heart J (1983) 0.75
[Substrate specificity of sweet almond beta-glucosidase]. Biokhimiia (1977) 0.75
Metabolism of zimelidine in rat, dog and man. Identification and synthesis of the principal metabolites. Arzneimittelforschung (1981) 0.75
[A journey in life]. Vardfacket (1980) 0.75
Acute symptomatic disk prolapse. Clinical manifestations and therapeutic considerations. Phys Ther (1979) 0.75
Mesenteric vascular gas secondary to ischemic bowel in transmesenteric hernia. Radiology (1981) 0.75
[Beta-glycosidase system of sunflowers. Isolation of enzyme and study of their substrate specificity]. Biokhimiia (1980) 0.75
Functional brain imaging. Recent Dev Alcohol (1985) 0.75
Antidepressant agents. 1. Chemistry and pharmacology of amino-substituted spiro(5H-dibenzo(a,d)cycloheptene-5,1'-cycloalkanes). J Med Chem (1974) 0.75